Animals
determining treatment efficacy
d-luciferin
HEPES-buffered saline
infected
luciferase activity
Mice bearing the orthotopic model
mice with the pseudo-metastatic model
orthotopic model
our targeted formulations
peptide-targeted SL[DXR]
preclinical models
retrovirally-transduced cells
Scrambled peptide-functionalized liposomes
SL[DXR]
Survival times
test the effects
the GI-LI-N cell line
These therapeutic schedules
time-dependent anti-tumor activity
untargeted
visualized
